I know the new strain of coronavirus is bad, but in the face of impending doom, I’m likely to find humor.
Anyone who has had more aggressive disease-modifying therapies (DMTs) like Lemtrada (alemtuzumab) and Ocrevus (ocrelizumab) likely has a compromised immune system. After all, this is exactly what they’re trying to achieve: reducing our B-lymphocytes to stop them attacking the protective coating on our nerves, called myelin.
I was severely annoyed at the time. Sure, it was because of the risk of me getting progressive multifocal leukoencephalopathy, a rare brain disease, but I had to get up at 5 a.m. — which is only an hour after I go to bed!
But with the subsequent spread of the new coronavirus, stopping anything that will destroy my B-lymphocytes further turns out to be a good thing. After all, B-lymphocytes might be behind the worsening of my MS, but they’re also my antibody factories.
No wonder much of the plot of “Catch-22” revolved around medicine.
However, it’s indubitably too late anyway. All of my MS medical professionals seem to think there’s little chance of my immune system recovering. I just had a full steroids course and a blood test. We’ll see.
As with much of my MS journey, at least we’ve done the best we can, even if this time it was a fluke. We were aiming to get me back on Ocrevus, but for the foreseeable future, that will be a big no.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?